Search research articles
Contact Us
Filters
Showing results (121-130 of 195) with videos related to
Page
of 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2005
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease
Michele T M Hu, Christoph Scherfler, Naheed L Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 26, 2014
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myeloma
K Martin Kortuem, Kaitlyn Zidich, Steven R Schuster, et al.
Molecules (Basel, Switzerland)
|
September 23, 2022
Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents
Badrud Duza Mohammad, Mirza Shahed Baig, Neeraj Bhandari, et al.
Annals of Medicine and Surgery (2012)
|
June 26, 2023
Drug target of natural products and COVID-19: how far has science progressed?
Kannan Raman, Kalirajan Rajagopal, B Ramesh, et al.
Plos One
|
April 5, 2024
Using a data-driven approach to define post-COVID conditions in US electronic health record data
Kathleen M Andersen, Farid L Khan, Peter W Park, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 11, 2005
Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow-up over 10 years
Naheed L Khan, Wagner Horta, Louise Eunson, et al.
Plos One
|
January 16, 2026
Gamma irradiation crosslinked fluorescent nanocarbon based biodegradable hydrogel for controlled release of antibiotics
Rajeshwar Vodeti, Mokhtar Rejili, Venkata Ramana Singamaneni, et al.
The Clinical Neuropsychologist
|
June 22, 2016
Latent profile analysis of regression-based norms demonstrates relationship of compounding MS symptom burden and negative work events
Seth E Frndak, Audrey M Smerbeck, Lauren N Irwin, et al.
Recent Advances in Drug Delivery and Formulation
|
September 3, 2022
Recent Advancements in Hyperthermia-Driven Controlled Drug Delivery from Nanotherapeutics
Mirza Shahed Baig, Mohammad Akiful Haque, Teja Kumar Reddy Konatham, et al.
Journal of the American Medical Directors Association
|
December 13, 2025
COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024-January 2025: An Ecological Analysis
Farid L Khan, Jenny Boucher, Timothy L Wiemken, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 195) with videos related to
Sort By:
Page
of 20
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2005
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease
Michele T M Hu, Christoph Scherfler, Naheed L Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 26, 2014
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myeloma
K Martin Kortuem, Kaitlyn Zidich, Steven R Schuster, et al.
Molecules (Basel, Switzerland)
|
September 23, 2022
Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents
Badrud Duza Mohammad, Mirza Shahed Baig, Neeraj Bhandari, et al.
Annals of Medicine and Surgery (2012)
|
June 26, 2023
Drug target of natural products and COVID-19: how far has science progressed?
Kannan Raman, Kalirajan Rajagopal, B Ramesh, et al.
Plos One
|
April 5, 2024
Using a data-driven approach to define post-COVID conditions in US electronic health record data
Kathleen M Andersen, Farid L Khan, Peter W Park, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 11, 2005
Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow-up over 10 years
Naheed L Khan, Wagner Horta, Louise Eunson, et al.
Plos One
|
January 16, 2026
Gamma irradiation crosslinked fluorescent nanocarbon based biodegradable hydrogel for controlled release of antibiotics
Rajeshwar Vodeti, Mokhtar Rejili, Venkata Ramana Singamaneni, et al.
The Clinical Neuropsychologist
|
June 22, 2016
Latent profile analysis of regression-based norms demonstrates relationship of compounding MS symptom burden and negative work events
Seth E Frndak, Audrey M Smerbeck, Lauren N Irwin, et al.
Recent Advances in Drug Delivery and Formulation
|
September 3, 2022
Recent Advancements in Hyperthermia-Driven Controlled Drug Delivery from Nanotherapeutics
Mirza Shahed Baig, Mohammad Akiful Haque, Teja Kumar Reddy Konatham, et al.
Journal of the American Medical Directors Association
|
December 13, 2025
COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024-January 2025: An Ecological Analysis
Farid L Khan, Jenny Boucher, Timothy L Wiemken, et al.
Page
of 20